Skip to main content
Premium Trial:

Request an Annual Quote

GE s Trevor Hawkins Emerges as New Chief Science and Technology Officer at MDS

NEW YORK, April 29 (GenomeWeb News) - MDS announced yesterday that Trevor Hawkins, GE Healthcare's former president of molecular diagnostics, will join the company as its new chief science and technology officer.

 

In this newly created position, Hawkins will focus on "identifying technologies, strategic initiatives and alliances that will leverage the company's existing technology and provide new market opportunities," MDS said in a statement. He will start the job on May 2.

 

Before joining GE, Hawkins was the senior vice president of development and new business initiatives at Amersham Biosciences. Hawkins has also directed the US Department of Energy's Human Genome Project at the Joint Genome Institute.

 

He has a PhD in biochemistry from the University of Sussex/MRC Laboratory of Molecular Biology and a BS from the Universityof Sussex.

 

At MDS, Hawkins will report to CEO John Rogers.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.